You may also be interested in articles related to Bio-Reference Laboratories (BRLI):
BRLI currently processes nearly 4.6 million requisitions each year. A requisition form accompanies a patient specimen. It indicates the tests to be performed and the party to be invoiced for the tests. Clients include doctors, employers, clinics and governmental units. They have a network of over 80 patient service centers for collection of patient specimens.
In 2006, BRLI acquired GeneDx, a diagnostic genetic testing laboratory providing services to national and international customers. GeneDx specializes in testing for rare and complex genetic conditions through the use of DNA sequencing. In 2007 BRLI introduced the first commercially available genome-wide oligonucleotide microarray analysis testing useful for the diagnosis of,among other conditions, developmental disorders.
In 2008, BRLI became the first commercial laboratory in the world to offer NextGen
(high speed computerized sequencing) to analyze multi-gene conditions. These innovations have significantly grown GeneDx's business. The success and growth of GeneDx can be attributed to both the unique nature of our testing and the highly experienced clinicians and researchers who run the business. In addition to clinical testing operations, BRLI operates a clinical knowledge management service through the PSIMedica business unit. This system uses customer data from laboratory results, pharmaceutical data, claims data and other data sources to provide administrative and clinical decision support systems which enable our customers to provide quality and efficient healthcare to their populations.BRLI also operates a web-based connectivity portal solution for laboratories and physicians through their CareEvolve subsidiary. BRLI uses this portal ourselves to provide laboratory ordering and results to our physician customers. They also market and license this connectivity solution to other laboratories throughout the country.